Remove trial restrictions ▶ Start for $1

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Colorcon
McKesson
Moodys
Medtronic
Mallinckrodt

Last Updated: September 30, 2022

ZOLADEX Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions


Which patents cover Zoladex, and when can generic versions of Zoladex launch?

Zoladex is a drug marketed by Tersera and is included in two NDAs. There are two patents protecting this drug.

This drug has fifty patent family members in thirty-three countries.

The generic ingredient in ZOLADEX is goserelin acetate. There are five drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the goserelin acetate profile page.

DrugPatentWatch® Generic Entry Outlook for Zoladex

Indicators of Generic Entry

< Available with Subscription >

  Sign up for a Free Trial

Summary for ZOLADEX
Drug patent expirations by year for ZOLADEX
Drug Prices for ZOLADEX

See drug prices for ZOLADEX

Recent Clinical Trials for ZOLADEX

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Radboud University Medical CenterPhase 2
Xinhua Hospital, Shanghai Jiao Tong University School of MedicineN/A
NovartisPhase 2

See all ZOLADEX clinical trials

US Patents and Regulatory Information for ZOLADEX

ZOLADEX is protected by two US patents.

Patents protecting ZOLADEX

Automatically operable safety shield system for syringes
Patent Number: See Plans and Pricing
Patent Expiration: See Plans and Pricing

Automatically operable safety shield system for syringes
Patent Number: See Plans and Pricing
Patent Expiration: See Plans and Pricing

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Tersera ZOLADEX goserelin acetate IMPLANT;IMPLANTATION 019726-001 Dec 29, 1989 RX Yes Yes See Plans and Pricing See Plans and Pricing Y See Plans and Pricing
Tersera ZOLADEX goserelin acetate IMPLANT;IMPLANTATION 020578-001 Jan 11, 1996 RX Yes Yes See Plans and Pricing See Plans and Pricing Y See Plans and Pricing
Tersera ZOLADEX goserelin acetate IMPLANT;IMPLANTATION 019726-001 Dec 29, 1989 RX Yes Yes See Plans and Pricing See Plans and Pricing Y See Plans and Pricing
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for ZOLADEX

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Tersera ZOLADEX goserelin acetate IMPLANT;IMPLANTATION 020578-001 Jan 11, 1996 See Plans and Pricing See Plans and Pricing
Tersera ZOLADEX goserelin acetate IMPLANT;IMPLANTATION 019726-001 Dec 29, 1989 See Plans and Pricing See Plans and Pricing
Tersera ZOLADEX goserelin acetate IMPLANT;IMPLANTATION 019726-001 Dec 29, 1989 See Plans and Pricing See Plans and Pricing
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Express Scripts
Harvard Business School
Dow
McKesson
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.